Ki67, PCAD and CK7 expression was reduced up to tenfold in the tumour relative to non-tumour with 2—ninefold reductions in CD24, CD44, CD31, CD49 MENA, ECAD, EPCAM, CDX2, CK6 and CK13. This evidence concerns the gene CD44 and neoplasm.